OpenAlex
PricingAboutJobs
Log inGet started
Work

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II): A randomised, double-blind, non-inferiority trial

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Thrombosis and Haemostasis
DOI: 10.1160/th10-10-0679
Authors: Ola Dahl, Michael Huo, Andreas Kurth, Stefan Hantel, Karin Hermansson, Janet Schnee, Richard Friedman, Bengt Eriksson, for the RE-NOVATE II Study Group
Institutions: Thrombosis Research Institute, The University of Texas Southwestern Medical Center, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Boehringer Ingelheim (Germany), Boehringer Ingelheim (Sweden), Boehringer Ingelheim (United States), Medical University of South Carolina, Sahlgrenska University Hospital, University of Gothenburg
Language: English

Topic: Venous Thromboembolism Diagnosis and Management
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Keywords: dabigatran, enoxaparin, thromboprophylaxis, total hip arthroplasty, venous thromboembolism, direct thrombin inhibitors, extended prophylaxis, major bleeding, pulmonary embolism, deep vein thrombosis, non-inferiority
SDG: Good health and well-being

Open Access status: closed

Funders: Daiichi-Sankyo, Daiichi Sankyo Europe
OpenAlex ID: W1860620208
FWCI: 80.26
Cites: 30
Cited by: 442
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms